BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
US ˙ NasdaqGS ˙ US0887861088

Insider Shares25,612,643 shares
Total Insiders38
Insider Sentiment Score

The Insider Sentiment Score finds the companies being bought by corporate insiders.

It is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of insider accumulation. The scoring model uses a combination of the net number of insiders buying the prior 90 days, the total shares bought as a percentage of float, and the total shares owned by insiders. The number ranges from 0 to 100, with higher numbers indicating a higher level of accumulation to its peers, and 50 being the average.

Update Frequency: Daily

See Insiders Top Picks, which provides a list of companies with highest insider accumulation.

Officer Sentiment Score

The Officer Sentiment Score finds companies being bought by Corporate Officers.

By definition Corporate Officers are Corporate Insiders, but unlike some of the other Insiders (10% Shareholders and Board Members), Officers work for the company on a daily basis, and they user their own money when trading. (10% Shareholders and Board Members are often fund managers managing other people’s money.) As such, insider trades made by Officers are much more significant and should be treated appropriately.

Like the Insider Sentiment Score, the Officer Sentiment Score is the result of a sophisticated, multi-factor quantitative model that identifies companies with the highest levels of officer accumulation.

Update Frequency: Daily

See Insiders Top Picks, which provides a list of companies with highest insider sentiment.

Key Insider Metrics

This card shows how the company ranks along various insider metrics. The percentile rank shows how this company compares to other companies in the US markets. Higher rankings are indicative of better situations.

For example, it is generally accepted that insider buying is a positive indicator, so companies with more insider buying would rank higher than companies with less insider buying (or even insider selling).

Net Number of Insiders Buying (Rank)

-6 ( )

11124 out of 11323

Net Number of Insiders Buying is the total number of insiders buying minus the total number of insiders selling in the last 90 days. The percentile rank is shown here (range from 0 to 100%).

Percent of Float Bought by Insiders (Rank)

N/A

Percent of Float Bought by Insiders is the total number of shares purchased by insiders minus the total number of shares sold by insiders in the last 90 days, divided by the total float and multiplied by 100.

Insider Trading Chart

Bicycle Therapeutics plc - Depositary Receipt (Common Stock) insider trades are shown in the following chart. Insiders are officers, directors, or significant investors in a company. In general, it is generally illegal for insiders to make trades in their companies based on material, non-public information. This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.

Insider Roster and Profitability Metrics

This table shows the list known insiders, and is generated automatically from filings disclosed to the SEC. In addition to the names, most recent title, and director, officer, or 10% owner designation, we provide the latest disclosed holdings. Additionally, when possible we provide the historical trade performance for the insider. The historical trade performance is a weighted average of the performance of actual open-market purchase transactions made by the insider. For more information on how this is calculated, watch this YouTube webinar.

See our leaderboard of most profitable insider traders.

Insider Avg Profit (%) Shares
Owned
Split
Adjusted
Aquila Investments Iv 10% Owner - [10%] 1,957,961 1,957,961
Michael Anstey Director - [D] 1,751,437 1,751,437
Santiago Arroyo CHIEF DEVELOPMENT OFFICER - [O] 69,057 69,057
Baker Bros. Advisors Lp Director, 10% Owner - [D] [10%] 9,999,674 9,999,674
Kate Bingham Director - [D] 38,708 38,708
Janice Bourque Director - [D] 23,000 23,000
Innovation Capital (Jersey) Ltd Cambridge 10% Owner - [10%] 1,751,437 1,751,437
Nigel Crockett CHIEF BUSINESS OFFICER - [O] 51,053 51,053
Plc Glaxosmithkline 10% Owner - [10%] 1,910,531 1,910,531
Jose-Carlos Gutierrez-Ramos Director - [D] 23,000 23,000
Deborah Harland Director - [D] 1,915,275 1,915,275
Michael Charles Ferguson Hannay CHIEF PROD & SUPPLY CHAIN OFF - [O] 53,825 53,825
Insider Avg Profit (%) Shares
Owned
Split
Adjusted
Veronica GH Jordan Director - [D] 16,750 16,750
Lee Kalowski President and CFO - [O] 30,309 30,309
Nicholas Keen CHIEF SCIENTIFIC OFFICER - [O] 62,024 62,024
Richard N Kender Director - [D] 23,000 23,000
Kevin Lee CHIEF EXECUTIVE OFFICER, Director - [D] [O] 480,804 480,804
Pierre Legault Director - [D] 46,000 46,000
Peter Brian Leone 43,269
Alistair Milnes CHIEF OPERATING OFFICER - [O] 95,502 95,502
Carolyn Ng Director - [D] 1,427,151 1,427,151
Ag Novartis 10% Owner - [10%] 1,769,641 1,769,641
Bioventures Ltd Novartis 10% Owner - [10%] 1,769,641 1,769,641
Alessandro Riva Director - [D] 12,500 12,500
Sv Life Sciences Fund V Lp 10% Owner - [10%] 39,637 39,637
Insider Avg Profit (%) Shares
Owned
Split
Adjusted
SV Life Sciences Fund V (GP), LP 10% Owner - [10%] 39,637 39,637
SV Life Sciences Fund V Strategic Partners, L.P. 10% Owner - [10%] 39,637 39,637
Svlsf V, Llc 10% Owner - [10%] 39,637 39,637
Sands Stephen H. Director - [D] 17,393 17,393
Michael Skynner CHIEF TECHNOLOGY OFFICER - [O] 120,079 120,079
Dominic Smethurst Chief Medical Officer - [O] 36,699 36,699
Robert Charles Swanton Director - [D] 3,089 3,089
Capital Management Hk Ltd Tybourne 10% Owner - [10%] 1,957,961 1,957,961
Travis Alvin Thompson CHIEF ACCOUNTING OFFICER - [O] 31,521 31,521
Vertex Global Healthcare Fund I Pte Ltd. 10% Owner - [10%] 1,621,168 1,621,168
Eric Westin Chief Medical Officer - [O] 2,305 2,305
Gregory Paul Winter Director - [D] 186,927 186,927
Alethia Young Chief Financial Officer - [O] 45,186 45,186

Report errors via our new Insider Auditing Tool

Track Records of Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made in BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock). This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical .

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
2024-12-16 BAKER BROS. ADVISORS LP 42,369 15.3418 42,369 15.3418 650,017 2 15.3150 -1,135 -0.17
2024-12-16 BAKER BROS. ADVISORS LP 457,631 15.3418 457,631 15.3418 7,020,883
2024-12-13 BAKER BROS. ADVISORS LP 2,809 13.4979 2,809 13.4979 37,916
2024-12-13 BAKER BROS. ADVISORS LP 30,241 13.4979 30,241 13.4979 408,190
2024-12-13 BAKER BROS. ADVISORS LP 5,573 13.6288 5,573 13.6288 75,953
2024-12-13 BAKER BROS. ADVISORS LP 59,995 13.6288 59,995 13.6288 817,660
2024-12-13 BAKER BROS. ADVISORS LP 22,722 13.7242 22,722 13.7242 311,841
2024-12-13 BAKER BROS. ADVISORS LP 244,587 13.7242 244,587 13.7242 3,356,761
2024-12-13 BAKER BROS. ADVISORS LP 52,656 13.8040 52,656 13.8040 726,863

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) Insider Trades
Track Records of Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock). A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical .

The following table shows the most recent open market sales that were not part of an automatic trading plan.

Trade Date Insider Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
2025-07-03 Skynner Michael 966 7.4400 966 7.4400 7,187 63 6.9700 -454 -6.32
2025-07-03 Milnes Alistair 966 7.4400 966 7.4400 7,187
2025-07-03 Lee Kevin 3,193 7.4400 3,193 7.4400 23,756
2025-07-03 Hannay Michael Charles Ferguson 248 7.4400 248 7.4400 1,845
2025-07-03 Thompson Travis Alvin 100 7.4400 100 7.4400 744
2025-07-02 Skynner Michael 825 7.0900 825 7.0900 5,849
2025-07-02 Milnes Alistair 1,149 7.0900 1,149 7.0900 8,146
2025-07-02 Young Alethia 204 7.0900 204 7.0900 1,446
2025-07-02 Lee Kevin 2,268 7.0900 2,268 7.0900 16,080

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock) Insider Trades
Transaction History

Click the link icon to see the full transaction history. Transactions reported as part of a 10b5-1 automatic trading plan will have an X in the column marked 10b-5.

File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-08-14 2025-08-12 4 Swanton Robert Charles BCYC Ordinary Shares A - Award D 12,500 15,589
2025-08-14 3 Swanton Robert Charles BCYC Ordinary Shares D 3,089
2025-07-07 2025-07-02 4 Young Alethia BCYC Ordinary Shares S - Sale D 7.0900 -204 -1 45,186
2025-07-07 2025-07-03 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 7.4400 -100 -1 31,521
2025-07-07 2025-07-02 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 7.0900 -206 -1 31,621
2025-07-07 2025-07-03 4 Hannay Michael Charles Ferguson BCYC Ordinary Shares S - Sale D 7.4400 -248 -2 53,825
2025-07-07 2025-07-02 4 Hannay Michael Charles Ferguson BCYC Ordinary Shares S - Sale D 7.0900 -474 -3 54,073
2025-07-07 2025-07-03 4 Milnes Alistair BCYC Ordinary Shares S - Sale D 7.4400 -966 -7 95,502
2025-07-07 2025-07-02 4 Milnes Alistair BCYC Ordinary Shares S - Sale D 7.0900 -1,149 -8 96,468
2025-07-07 2025-07-03 4 Skynner Michael BCYC Ordinary Shares S - Sale D 7.4400 -966 -7 120,079
2025-07-07 2025-07-02 4 Skynner Michael BCYC Ordinary Shares S - Sale D 7.0900 -825 -6 121,045
2025-07-07 2025-07-03 4 Lee Kevin BCYC Ordinary Shares S - Sale D 7.4400 -3,193 -24 480,804
2025-07-07 2025-07-02 4 Lee Kevin BCYC Ordinary Shares S - Sale D 7.0900 -2,268 -16 483,997
2025-04-04 2025-04-03 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 7.4800 -109 -1 31,827
2025-04-04 2025-04-02 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 8.0200 -210 -2 31,936
2025-04-04 2025-04-03 4 Hannay Michael Charles Ferguson BCYC Ordinary Shares S - Sale D 7.4800 -266 -2 54,547
2025-04-04 2025-04-02 4 Hannay Michael Charles Ferguson BCYC Ordinary Shares S - Sale D 8.0200 -467 -4 54,813
2025-04-04 2025-04-03 4 Lee Kevin BCYC Ordinary Shares S - Sale D 7.4800 -3,432 -26 486,265
2025-04-04 2025-04-02 4 Lee Kevin BCYC Ordinary Shares S - Sale D 8.0200 -2,237 -18 489,697
2025-04-04 2025-04-03 4 Milnes Alistair BCYC Ordinary Shares S - Sale D 7.4800 -1,038 -8 97,617
2025-04-04 2025-04-02 4 Milnes Alistair BCYC Ordinary Shares S - Sale D 8.0200 -1,133 -9 98,655
2025-04-04 2025-04-03 4 Skynner Michael BCYC Ordinary Shares S - Sale D 7.4800 -1,038 -8 121,870
2025-04-04 2025-04-02 4 Skynner Michael BCYC Ordinary Shares S - Sale D 8.0200 -814 -7 122,908
2025-04-04 2025-04-02 4 Young Alethia BCYC Ordinary Shares S - Sale D 8.0200 -215 -2 45,390
2025-03-27 2025-03-25 4 Riva Alessandro BCYC Ordinary Shares A - Award D 12,500 12,500
2025-03-27 3 Westin Eric BCYC Ordinary Shares D 2,305
2025-01-06 2025-01-03 4 Milnes Alistair BCYC Ordinary Shares S - Sale D 14.7500 -936 -14 99,788
2025-01-06 2025-01-02 4 Milnes Alistair BCYC Ordinary Shares S - Sale D 14.0900 -4,578 -65 100,724
2025-01-06 2025-01-02 4 Milnes Alistair BCYC Ordinary Shares A - Award D 35,000 105,302
2025-01-06 2025-01-02 4 Kender Richard N BCYC Ordinary Shares A - Award D 6,250 23,000
2025-01-06 2025-01-02 4 Sands Stephen H. BCYC Ordinary Shares A - Award D 5,393 17,393
2025-01-06 2025-01-03 4 Lee Kevin BCYC Ordinary Shares S - Sale D 14.7500 -3,092 -46 491,934
2025-01-06 2025-01-02 4 Lee Kevin BCYC Ordinary Shares S - Sale D 14.0900 -9,038 -127 495,026
2025-01-06 2025-01-02 4 Lee Kevin BCYC Ordinary Shares A - Award D 123,200 504,064
2025-01-06 2025-01-03 4 Hannay Michael Charles Ferguson BCYC Ordinary Shares S - Sale D 14.7500 -239 -4 55,280
2025-01-06 2025-01-02 4 Hannay Michael Charles Ferguson BCYC Ordinary Shares S - Sale D 14.0900 -1,879 -26 55,519
2025-01-06 2025-01-02 4 Hannay Michael Charles Ferguson BCYC Ordinary Shares A - Award D 35,000 57,398
2025-01-06 2025-01-03 4 Skynner Michael BCYC Ordinary Shares S - Sale D 14.7500 -936 -14 123,722
2025-01-06 2025-01-02 4 Skynner Michael BCYC Ordinary Shares S - Sale D 14.0900 -3,287 -46 124,658
2025-01-06 2025-01-02 4 Skynner Michael BCYC Ordinary Shares A - Award D 35,000 127,945
2025-01-06 2025-01-03 4 Crockett Nigel BCYC Ordinary Shares S - Sale D 14.7500 -936 -14 51,053
2025-01-06 2025-01-02 4 Crockett Nigel BCYC Ordinary Shares S - Sale D 14.0900 -2,583 -36 51,989
2025-01-06 2025-01-02 4 Crockett Nigel BCYC Ordinary Shares A - Award D 8,750 54,572
2025-01-06 2025-01-02 4 Arroyo Santiago BCYC Ordinary Shares S - Sale D 14.0900 -4,943 -70 69,057
2025-01-06 2025-01-02 4 Arroyo Santiago BCYC Ordinary Shares A - Award D 35,000 74,000
2025-01-06 2025-01-02 4 Young Alethia BCYC Ordinary Shares S - Sale D 14.0900 -1,395 -20 45,605
2025-01-06 2025-01-02 4 Young Alethia BCYC Ordinary Shares A - Award D 35,000 47,000
2025-01-06 2025-01-06 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 15.0000 -2,686 -40 32,146
2025-01-06 2025-01-03 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 14.7500 -159 -2 34,832
2025-01-06 2025-01-02 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 14.0900 -1,750 -25 34,991
2025-01-06 2025-01-02 4 Thompson Travis Alvin BCYC Ordinary Shares A - Award D 17,500 36,741
2025-01-06 2025-01-02 4 Legault Pierre BCYC Ordinary Shares A - Award D 12,500 46,000
2025-01-06 2025-01-02 4 Bourque Janice BCYC Ordinary Shares A - Award D 6,250 23,000
2025-01-06 2025-01-02 4 Winter Gregory Paul BCYC Ordinary Shares A - Award D 6,250 186,927
2025-01-06 2025-01-02 4 Gutierrez-Ramos Jose-Carlos BCYC Ordinary Shares A - Award D 6,250 23,000
2025-01-06 2025-01-02 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares A - Award I 4,400 9,999,674
2025-01-06 2025-01-02 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares A - Award I 4,400 918,483
2024-12-17 2024-12-16 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares P - Purchase I 15.3418 457,631 7,021 9,995,274
2024-12-17 2024-12-16 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares P - Purchase I 15.3418 42,369 650 914,083
2024-12-17 2024-12-13 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares P - Purchase I 13.8040 566,814 7,824 9,537,643
2024-12-17 2024-12-13 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares P - Purchase I 13.8040 52,656 727 871,714
2024-12-17 2024-12-13 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares P - Purchase I 13.7242 244,587 3,357 8,970,829
2024-12-17 2024-12-13 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares P - Purchase I 13.7242 22,722 312 819,058
2024-12-17 2024-12-13 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares P - Purchase I 13.6288 59,995 818 8,726,242
2024-12-17 2024-12-13 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares P - Purchase I 13.6288 5,573 76 796,336
2024-12-17 2024-12-13 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares P - Purchase I 13.4979 30,241 408 8,666,247
2024-12-17 2024-12-13 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares P - Purchase I 13.4979 2,809 38 790,763
2024-11-13 2024-11-11 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 24.8200 -231 -6 19,241
2024-11-13 2024-11-11 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 24.7700 -209 -5 19,472
2024-11-13 2024-11-11 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 25.2100 -3,241 -82 19,681
2024-11-13 2024-11-11 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 25.0500 -1,109 -28 22,922
2024-11-13 2024-11-11 4 Thompson Travis Alvin BCYC Ordinary Shares M - Exercise D 9.8200 1,109 11 24,031
2024-11-13 2024-11-11 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 25.0100 -154 -4 22,922
2024-11-13 2024-11-11 4 Thompson Travis Alvin BCYC Ordinary Shares M - Exercise D 8.2100 154 1 23,076
2024-11-13 2024-11-11 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 25.0500 -1,312 -33 22,922
2024-11-13 2024-11-11 4 Thompson Travis Alvin BCYC Ordinary Shares M - Exercise D 1.8700 1,312 2 24,234
2024-10-04 2024-10-03 4 Milnes Alistair BCYC Ordinary Shares S - Sale D 22.2600 -972 -22 70,302
2024-10-04 2024-10-03 4 Skynner Michael BCYC Ordinary Shares S - Sale D 22.2600 -972 -22 92,945
2024-10-04 2024-10-03 4 Hannay Michael Charles Ferguson BCYC Ordinary Shares S - Sale D 22.2600 -247 -5 22,398
2024-10-04 2024-10-03 4 Lee Kevin BCYC Ordinary Shares S - Sale D 22.2600 -3,212 -71 380,864
2024-10-04 2024-10-03 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 22.2600 -153 -3 22,922
2024-10-04 2024-10-03 4 Crockett Nigel BCYC Ordinary Shares S - Sale D 22.2600 -972 -22 45,822
2024-07-08 2024-07-03 4 Hannay Michael Charles Ferguson BCYC Ordinary Shares S - Sale D 19.6400 -246 -5 22,645
2024-07-08 2024-07-03 4 Milnes Alistair BCYC Ordinary Shares S - Sale D 19.6400 -967 -19 71,274
2024-07-08 2024-07-03 4 Lee Kevin BCYC Ordinary Shares S - Sale D 19.6400 -3,194 -63 384,076
2024-07-08 2024-07-03 4 Crockett Nigel BCYC Ordinary Shares S - Sale D 19.6400 -967 -19 46,794
2024-07-08 2024-07-03 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 19.6400 -779 -15 62,024
2024-07-08 2024-07-03 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 19.6400 -148 -3 23,075
2024-07-08 2024-07-03 4 Skynner Michael BCYC Ordinary Shares S - Sale D 19.6400 -967 -19 93,917
2024-06-20 2024-06-17 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares C - Conversion I 2,186,686 8,636,006
2024-06-20 2024-06-17 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares C - Conversion I 196,098 787,954
2024-04-22 2024-04-18 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares A - Award I 12,000 6,449,320
2024-04-22 2024-04-18 4 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares A - Award I 12,000 6,449,320
2024-04-18 3 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares I 6,437,320
2024-04-18 3 BAKER BROS. ADVISORS LP See Footnotes BCYC American Depositary Shares I 579,856
2024-04-12 2024-04-11 4 Hannay Michael Charles Ferguson BCYC Ordinary Shares S - Sale D 22.4900 -257 -6 22,891
2024-04-05 2024-04-03 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 23.8100 -152 -4 23,223
2024-04-05 2024-04-03 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 23.8100 -790 -19 62,803
2024-04-05 2024-04-03 4 Crockett Nigel BCYC Ordinary Shares S - Sale D 23.8100 -955 -23 47,761
2024-04-05 2024-04-03 4 Milnes Alistair BCYC Ordinary Shares S - Sale D 23.8100 -955 -23 72,241
2024-04-05 2024-04-03 4 Skynner Michael BCYC Ordinary Shares S - Sale D 23.8100 -955 -23 94,884
2024-04-05 2024-04-03 4 Lee Kevin BCYC Ordinary Shares S - Sale D 23.8100 -3,158 -75 387,270
2024-03-21 3 Hannay Michael Charles Ferguson BCYC Ordinary Shares D 23,148
2024-02-21 2024-02-20 4 Sands Stephen H. BCYC Ordinary Shares A - Award D 12,000 12,000
2024-02-08 2024-02-06 4 Arroyo Santiago BCYC Ordinary Shares A - Award D 21,660 39,000
2024-01-04 2024-01-03 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 17.5000 -604 -11 23,375
2024-01-04 2024-01-02 4 Thompson Travis Alvin BCYC Ordinary Shares A - Award D 16,000 23,979
2024-01-04 2024-01-02 4 Legault Pierre BCYC Ordinary Shares A - Award D 12,000 33,500
2024-01-04 2024-01-03 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 17.5000 -2,640 -46 63,593
2024-01-04 2024-01-02 4 Keen Nicholas BCYC Ordinary Shares A - Award D 28,000 66,233
2024-01-04 2024-01-02 4 Bourque Janice BCYC Ordinary Shares A - Award D 6,000 16,750
2024-01-04 2024-01-02 4 Gutierrez-Ramos Jose-Carlos BCYC Ordinary Shares A - Award D 6,000 16,750
2024-01-04 2024-01-02 4 Winter Gregory Paul BCYC Ordinary Shares A - Award D 6,000 180,677
2024-01-04 2024-01-02 4 Jordan Veronica GH BCYC Ordinary Shares A - Award D 6,000 16,750
2024-01-04 2024-01-02 4 Kender Richard N BCYC Ordinary Shares A - Award D 6,000 16,750
2024-01-04 2024-01-02 4 Arroyo Santiago BCYC Ordinary Shares A - Award D 17,340 17,340
2024-01-04 2024-01-03 4 Crockett Nigel BCYC Ordinary Shares S - Sale D 17.5000 -2,643 -46 48,716
2024-01-04 2024-01-02 4 Crockett Nigel BCYC Ordinary Shares A - Award D 22,000 51,359
2024-01-04 2024-01-03 4 Milnes Alistair BCYC Ordinary Shares S - Sale D 17.5000 -2,643 -46 73,196
2024-01-04 2024-01-02 4 Milnes Alistair BCYC Ordinary Shares A - Award D 39,000 75,839
2024-01-04 2024-01-02 4 Young Alethia BCYC Ordinary Shares A - Award D 12,000 12,000
2024-01-04 2024-01-03 4 Lee Kevin BCYC Ordinary Shares S - Sale D 17.5000 -8,703 -152 390,428
2024-01-04 2024-01-02 4 Lee Kevin BCYC Ordinary Shares A - Award D 77,000 399,131
2024-01-04 2024-01-03 4 Skynner Michael BCYC Ordinary Shares S - Sale D 17.5000 -2,643 -46 95,839
2024-01-04 2024-01-02 4 Skynner Michael BCYC Ordinary Shares A - Award D 28,000 98,482
2023-10-05 2023-10-03 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 20.0000 -54 -1 7,979
2023-10-05 2023-10-03 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 20.0000 -272 -5 38,233
2023-10-05 2023-10-03 4 Crockett Nigel BCYC Ordinary Shares S - Sale D 20.0000 -442 -9 29,359
2023-10-05 2023-10-03 4 Lee Kevin BCYC Ordinary Shares S - Sale D 20.0000 -1,470 -29 322,131
2023-10-05 2023-10-03 4 Milnes Alistair BCYC Ordinary Shares S - Sale D 20.0000 -442 -9 36,839
2023-10-05 2023-10-03 4 Skynner Michael BCYC Ordinary Shares S - Sale D 20.0000 -442 -9 70,482
2023-07-06 2023-07-03 4 Crockett Nigel BCYC Ordinary Shares S - Sale D 25.1000 -451 -11 29,801
2023-07-06 2023-07-03 4 Lee Kevin BCYC Ordinary Shares S - Sale D 25.1000 -1,498 -38 323,601
2023-07-06 2023-07-03 4 Milnes Alistair BCYC Ordinary Shares S - Sale D 25.1000 -451 -11 37,281
2023-07-06 2023-07-03 4 Thompson Travis Alvin BCYC Ordinary Shares S - Sale D 25.1000 -61 -2 8,033
2023-07-06 2023-07-03 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 25.1000 -336 -8 38,505
2023-07-06 2023-07-03 4 Skynner Michael BCYC Ordinary Shares S - Sale D 25.1000 -451 -11 70,924
2023-07-03 3 Thompson Travis Alvin BCYC Ordinary Shares D 8,094
2023-04-05 2023-04-03 4 Skynner Michael BCYC Ordinary Shares S - Sale D 21.1100 -447 -9 71,375
2023-04-05 2023-04-03 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 21.1100 -319 -7 38,841
2023-04-05 2023-04-03 4 Milnes Alistair BCYC Ordinary Shares S - Sale D 21.1100 -447 -9 37,732
2023-04-05 2023-04-03 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 21.1100 -376 -8 30,309
2023-04-05 2023-04-03 4 Lee Kevin BCYC Ordinary Shares S - Sale D 21.1100 -1,486 -31 325,099
2023-04-05 2023-04-03 4 Crockett Nigel BCYC Ordinary Shares S - Sale D 21.1100 -447 -9 30,252
2023-01-05 2023-01-03 4 Gutierrez-Ramos Jose-Carlos BCYC Ordinary Shares A - Award D 5,750 10,750
2023-01-05 2023-01-03 4 Jordan Veronica GH BCYC Ordinary Shares A - Award D 5,750 10,750
2023-01-05 2023-01-03 4 Skynner Michael BCYC Ordinary Shares S - Sale D 29.0600 -1,801 -52 71,822
2023-01-05 2023-01-03 4 Skynner Michael BCYC Ordinary Shares A - Award D 17,500 73,623
2023-01-05 2023-01-03 4 Lee Kevin BCYC Ordinary Shares S - Sale D 29.0600 -6,000 -174 326,585
2023-01-05 2023-01-03 4 Lee Kevin BCYC Ordinary Shares A - Award D 57,500 332,585
2023-01-05 2023-01-03 4 Winter Gregory Paul BCYC Ordinary Shares A - Award D 5,750 174,677
2023-01-05 2023-01-03 4 Legault Pierre BCYC Ordinary Shares A - Award D 11,500 21,500
2023-01-05 2023-01-03 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 29.0600 -1,815 -53 30,685
2023-01-05 2023-01-03 4 Kalowski Lee BCYC Ordinary Shares A - Award D 17,500 32,500
2023-01-05 2023-01-03 4 Kender Richard N BCYC Ordinary Shares A - Award D 5,750 10,750
2023-01-05 2023-01-03 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 29.0600 -1,817 -53 39,160
2023-01-05 2023-01-03 4 Keen Nicholas BCYC Ordinary Shares A - Award D 17,500 40,977
2023-01-05 2023-01-03 4 Crockett Nigel BCYC Ordinary Shares S - Sale D 29.0600 -1,801 -52 30,699
2023-01-05 2023-01-03 4 Crockett Nigel BCYC Ordinary Shares A - Award D 17,500 32,500
2023-01-05 2023-01-03 4 Bourque Janice BCYC Ordinary Shares A - Award D 5,750 10,750
2023-01-05 2023-01-03 4 Smethurst Dominic BCYC Ordinary Shares S - Sale D 29.0600 -1,801 -52 36,699
2023-01-05 2023-01-03 4 Smethurst Dominic BCYC Ordinary Shares A - Award D 17,500 38,500
2023-01-05 2023-01-03 4 Milnes Alistair BCYC Ordinary Shares S - Sale D 29.0600 -1,801 -52 38,179
2023-01-05 2023-01-03 4 Milnes Alistair BCYC Ordinary Shares A - Award D 17,500 39,980
2022-03-29 2022-03-25 4 Milnes Alistair BCYC Employee Stock Option (right to buy) M - Exercise D 20.12 5,155 46,845
2022-03-29 2022-03-25 4 Milnes Alistair BCYC Ordinary Shares M - Exercise D 20.1200 5,155 104 22,480
2022-03-29 3/A Milnes Alistair BCYC Ordinary Shares D 2,325
2022-01-05 2022-01-03 4 Jordan Veronica GH BCYC Stock Option (right to buy) A - Award D 60.87 10,000 10,000
2022-01-05 2022-01-03 4 Jordan Veronica GH BCYC Ordinary Shares A - Award D 5,000 5,000
2022-01-05 2022-01-03 4 Winter Gregory Paul BCYC Stock Option (right to buy) A - Award D 60.87 10,000 10,000
2022-01-05 2022-01-03 4 Winter Gregory Paul BCYC Ordinary Shares A - Award D 5,000 168,927
2022-01-05 2022-01-03 4 Skynner Michael BCYC Employee Stock Option (right to buy) A - Award D 60.87 30,000 30,000
2022-01-05 2022-01-03 4 Skynner Michael BCYC Ordinary Shares A - Award D 15,000 56,123
2022-01-05 2022-01-03 4 Smethurst Dominic BCYC Employee Stock Option (right to buy) A - Award D 60.87 30,000 30,000
2022-01-05 2022-01-03 4 Smethurst Dominic BCYC Ordinary Shares A - Award D 15,000 21,000
2022-01-05 2022-01-03 4 Lee Kevin BCYC Employee Stock Option (right to buy) A - Award D 60.87 100,000 100,000
2022-01-05 2022-01-03 4 Lee Kevin BCYC Ordinary Shares A - Award D 50,000 275,085
2022-01-05 2022-01-03 4 Legault Pierre BCYC Stock Option (right to buy) A - Award D 60.87 20,000 20,000
2022-01-05 2022-01-03 4 Legault Pierre BCYC Ordinary Shares A - Award D 10,000 10,000
2022-01-05 2022-01-03 4 Kender Richard N BCYC Stock Option (right to buy) A - Award D 60.87 10,000 10,000
2022-01-05 2022-01-03 4 Kender Richard N BCYC Ordinary Shares A - Award D 5,000 5,000
2022-01-05 2022-01-03 4 Kalowski Lee BCYC Employee Stock Option (right to buy) A - Award D 60.87 30,000 30,000
2022-01-05 2022-01-03 4 Kalowski Lee BCYC Ordinary Shares A - Award D 15,000 15,000
2022-01-05 2022-01-03 4 Keen Nicholas BCYC Employee Stock Option (right to buy) A - Award D 60.87 30,000 30,000
2022-01-05 2022-01-03 4 Keen Nicholas BCYC Ordinary Shares A - Award D 15,000 23,477
2022-01-05 2022-01-03 4 Gutierrez-Ramos Jose-Carlos BCYC Stock Option (right to buy) A - Award D 60.87 10,000 10,000
2022-01-05 2022-01-03 4 Gutierrez-Ramos Jose-Carlos BCYC Ordinary Shares A - Award D 5,000 5,000
2022-01-05 2022-01-03 4 Crockett Nigel BCYC Employee Stock Option (right to buy) A - Award D 60.87 30,000 30,000
2022-01-05 2022-01-03 4 Crockett Nigel BCYC Ordinary Shares A - Award D 15,000 15,000
2022-01-05 2022-01-03 4 Bourque Janice BCYC Stock Option (right to buy) A - Award D 60.87 10,000 10,000
2022-01-05 2022-01-03 4 Bourque Janice BCYC Ordinary Shares A - Award D 5,000 5,000
2022-01-05 2022-01-03 4 Milnes Alistair BCYC Employee Stock Option (right to buy) A - Award D 60.87 100,000 100,000
2022-01-05 2022-01-03 4 Milnes Alistair BCYC Ordinary Shares A - Award D 15,000 15,000
2021-12-22 2021-12-21 4 Keen Nicholas BCYC Stock Option (Right to Buy) M - Exercise D 14.00 -15,477 161,927
2021-12-22 2021-12-21 4 Keen Nicholas BCYC Ordinary Shares M - Exercise D 14.0000 15,477 217 15,477
2021-12-22 2021-12-22 4 Legault Pierre BCYC Stock Option (Right to Buy) M - Exercise D 8.48 -97,860 23,312
2021-12-22 2021-12-22 4 Legault Pierre BCYC Ordinary Shares S - Sale D 58.0100 -97,860 -5,677 0
2021-12-22 2021-12-22 4 Legault Pierre BCYC Ordinary Shares M - Exercise D 8.4800 97,860 830 97,860
2021-12-22 2021-12-21 4 Legault Pierre BCYC Stock Option (Right to Buy) M - Exercise D 8.44 -44,537 121,172
2021-12-22 2021-12-21 4 Legault Pierre BCYC Ordinary Shares S - Sale D 57.1100 -44,537 -2,544 0
2021-12-22 2021-12-21 4 Legault Pierre BCYC Ordinary Shares M - Exercise D 8.4400 44,537 376 44,537
2021-12-22 2021-12-20 4 Legault Pierre BCYC Stock Option (Right to Buy) M - Exercise D 8.41 -7,603 165,709
2021-12-22 2021-12-20 4 Legault Pierre BCYC Ordinary Shares S - Sale D 57.0200 -7,603 -434 0
2021-12-22 2021-12-20 4 Legault Pierre BCYC Ordinary Shares M - Exercise D 8.4100 7,603 64 7,603
2021-10-18 2021-10-18 4 Lee Kevin BCYC Ordinary Shares S - Sale D 60.0000 -49 -3 225,085
2021-10-18 2021-10-15 4 Lee Kevin BCYC Ordinary Shares S - Sale D 60.0500 -320 -19 225,134
2021-10-18 2021-10-14 4 Lee Kevin BCYC Ordinary Shares S - Sale D 60.0000 -4,631 -278 225,454
2021-10-13 2021-10-11 4 Lee Kevin BCYC Ordinary Shares S - Sale D 54.6700 -598 -33 230,085
2021-10-13 2021-10-11 4 Lee Kevin BCYC Ordinary Shares S - Sale D 53.7700 -4,402 -237 230,683
2021-10-05 2021-10-05 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 45.1000 -2,178 -98 0
2021-10-05 2021-10-01 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 45.0000 -1,188 -53 2,178
2021-09-27 2021-09-23 4 Smethurst Dominic BCYC Employee Stock Option (right to buy) M - Exercise D 18.55 -6,000 114,000
2021-09-27 2021-09-23 4 Smethurst Dominic BCYC Ordinary Shares M - Exercise D 18.5500 6,000 111 6,000
2021-09-17 2021-09-16 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 45.0100 -1,955 -88 3,366
2021-09-17 2021-09-15 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 45.0000 -3,000 -135 5,321
2021-09-03 2021-09-02 4 Kalowski Lee BCYC Employee Stock Option (right to buy) M - Exercise D 9.82 -10,000 50,000
2021-09-03 2021-09-02 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 40.0000 -10,000 -400 0
2021-09-03 2021-09-02 4 Kalowski Lee BCYC Ordinary Shares M - Exercise D 9.8200 10,000 98 10,000
2021-09-03 2021-09-02 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 40.0000 -10,000 -400 8,321
2021-09-03 2021-09-02 4 Lee Kevin BCYC Ordinary Shares S - Sale D 40.0000 -5,000 -200 235,085
2021-09-03 2021-09-01 4 Lee Kevin BCYC Stock Option (right to buy) M - Exercise D 14.00 -22,890 306,252
2021-09-03 2021-09-01 4 Lee Kevin BCYC Ordinary Shares S - Sale D 38.0800 -1,796 -68 240,085
2021-09-03 2021-09-01 4 Lee Kevin BCYC Ordinary Shares S - Sale D 37.5200 -17,098 -642 241,881
2021-09-03 2021-09-01 4 Lee Kevin BCYC Ordinary Shares S - Sale D 36.3800 -8,191 -298 258,979
2021-09-03 2021-09-01 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 22,890 320 267,170
2021-08-31 2021-08-31 4 Lee Kevin BCYC Stock Option (right to buy) M - Exercise D 14.00 -10,420 329,142
2021-08-31 2021-08-31 4 Lee Kevin BCYC Ordinary Shares S - Sale D 37.0800 -1,272 -47 244,280
2021-08-31 2021-08-31 4 Lee Kevin BCYC Ordinary Shares S - Sale D 36.2300 -9,953 -361 245,552
2021-08-31 2021-08-31 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 10,420 146 255,505
2021-08-31 2021-08-27 4 Lee Kevin BCYC Stock Option (right to buy) M - Exercise D 14.00 -1,808 339,562
2021-08-31 2021-08-27 4 Lee Kevin BCYC Ordinary Shares S - Sale D 36.0200 -1,808 -65 245,085
2021-08-31 2021-08-27 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 1,808 25 246,893
2021-08-27 2021-08-27 4 Kalowski Lee BCYC Stock Option (Right to Buy) M - Exercise D 8.73 -7,950 5,768
2021-08-27 2021-08-27 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 35.1500 -7,950 -279 0
2021-08-27 2021-08-27 4 Kalowski Lee BCYC Ordinary Shares M - Exercise D 8.7300 7,950 69 7,950
2021-08-27 2021-08-26 4 Kalowski Lee BCYC Stock Option (Right to Buy) M - Exercise D 8.76 -550 13,718
2021-08-27 2021-08-26 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 35.0400 -550 -19 0
2021-08-27 2021-08-26 4 Kalowski Lee BCYC Ordinary Shares M - Exercise D 8.7600 550 5 550
2021-08-25 2021-08-23 4 Kalowski Lee BCYC Stock Option (Right to Buy) M - Exercise D 1.60 -7,500 59,774
2021-08-25 2021-08-23 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 33.0200 -7,500 -248 0
2021-08-25 2021-08-23 4 Kalowski Lee BCYC Ordinary Shares M - Exercise D 1.6000 7,500 12 7,500
2021-07-30 2021-07-29 4 Kalowski Lee BCYC Stock Option (Right to Buy) M - Exercise D 1.63 -12,500 67,274
2021-07-30 2021-07-29 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 32.8100 -300 -10 0
2021-07-30 2021-07-29 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 32.1300 -3,204 -103 300
2021-07-30 2021-07-29 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 31.2400 -8,996 -281 3,504
2021-07-30 2021-07-29 4 Kalowski Lee BCYC Ordinary Shares M - Exercise D 1.6300 12,500 20 12,500
2021-07-27 2021-07-26 4 Lee Kevin BCYC Stock Option (right to buy) M - Exercise D 14.00 -100 341,370
2021-07-27 2021-07-26 4 Lee Kevin BCYC Ordinary Shares S - Sale D 36.0000 -100 -4 245,085
2021-07-27 2021-07-26 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 100 1 245,185
2021-07-27 2021-07-23 4 Lee Kevin BCYC Stock Option (right to buy) M - Exercise D 14.00 -4,782 341,470
2021-07-27 2021-07-23 4 Lee Kevin BCYC Ordinary Shares S - Sale D 36.0200 -4,782 -172 245,085
2021-07-27 2021-07-23 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 4,782 67 249,867
2021-07-20 2021-07-14 4/A BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. BCYC Ordinary Shares S - Sale I 34.0076 -917 -31 38,708
2021-07-20 2021-07-14 4/A BINGHAM KATE By SV Life Sciences Fund V, L.P. BCYC Ordinary Shares S - Sale I 34.0076 -43,378 -1,475 1,831,671
2021-07-20 2021-07-13 4/A BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. BCYC Ordinary Shares S - Sale I 33.5000 -12 -0 39,625
2021-07-20 2021-07-13 4/A BINGHAM KATE By SV Life Sciences Fund V, L.P. BCYC Ordinary Shares S - Sale I 33.5000 -588 -20 1,875,049
2021-07-16 2021-07-14 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 35.0000 -10,000 -350 18,321
2021-07-16 2021-07-16 4 Lee Kevin BCYC Stock Option (right to buy) M - Exercise D 14.00 -609 346,252
2021-07-16 2021-07-16 4 Lee Kevin BCYC Ordinary Shares S - Sale D 34.0000 -609 -21 245,085
2021-07-16 2021-07-16 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 609 9 245,694
2021-07-16 2021-07-15 4 Lee Kevin BCYC Stock Option (right to buy) M - Exercise D 14.00 -21,970 346,861
2021-07-16 2021-07-15 4 Lee Kevin BCYC Ordinary Shares S - Sale D 34.2800 -21,970 -753 245,085
2021-07-16 2021-07-15 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 21,970 308 267,055
2021-07-15 2021-07-14 4 BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. BCYC Ordinary Shares S - Sale I 34.0076 -917 -31 38,708
2021-07-15 2021-07-14 4 BINGHAM KATE By SV Life Sciences Fund V, L.P. BCYC Ordinary Shares S - Sale I 34.0076 -43,378 -1,475 1,831,671
2021-07-15 2021-07-13 4 BINGHAM KATE By SV Life Sciences Fund V Strategic Partners, L.P. BCYC Ordinary Shares S - Sale I 33.5000 -12 -0 39,625
2021-07-15 2021-07-13 4 BINGHAM KATE By SV Life Sciences Fund V, L.P. BCYC Ordinary Shares S - Sale I 33.5000 -588 -20 1,875,049
2021-07-14 2021-07-14 4 Lee Kevin BCYC Stock Option (right to buy) M - Exercise D 14.00 -8,331 368,831
2021-07-14 2021-07-14 4 Lee Kevin BCYC Ordinary Shares S - Sale D 35.1600 -53 -2 245,085
2021-07-14 2021-07-14 4 Lee Kevin BCYC Ordinary Shares S - Sale D 34.8900 -9,084 -317 245,138
2021-07-14 2021-07-14 4 Lee Kevin BCYC Ordinary Shares S - Sale D 33.8500 -2,686 -91 254,222
2021-07-14 2021-07-14 4 Lee Kevin BCYC Ordinary Shares S - Sale D 32.9300 -2,642 -87 256,908
2021-07-14 2021-07-14 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 8,331 117 259,550
2021-07-14 2021-07-13 4 Lee Kevin BCYC Stock Option (right to buy) M - Exercise D 14.00 -35,446 377,162
2021-07-14 2021-07-13 4 Lee Kevin BCYC Ordinary Shares S - Sale D 34.0000 -11,194 -381 251,219
2021-07-14 2021-07-13 4 Lee Kevin BCYC Ordinary Shares S - Sale D 33.0900 -5,788 -192 262,413
2021-07-14 2021-07-13 4 Lee Kevin BCYC Ordinary Shares S - Sale D 32.4200 -21,979 -713 268,201
2021-07-14 2021-07-13 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 35,446 496 290,180
2021-07-14 2021-07-12 4 Lee Kevin BCYC Stock Option (right to buy) M - Exercise D 14.00 -1,936 412,608
2021-07-14 2021-07-12 4 Lee Kevin BCYC Ordinary Shares S - Sale D 32.0400 -1,936 -62 254,734
2021-07-14 2021-07-12 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 1,936 27 256,670
2021-07-14 2021-07-13 4 Crockett Nigel BCYC Employee Stock Option (right to buy) M - Exercise D 15.36 -13,019 30,764
2021-07-14 2021-07-13 4 Crockett Nigel BCYC Employee Stock Option (right to buy) M - Exercise D 9.82 -19,256 38,750
2021-07-14 2021-07-13 4 Crockett Nigel BCYC Employee Stock Option (right to buy) M - Exercise D 11.66 -40,426 62,660
2021-07-14 2021-07-13 4 Crockett Nigel BCYC Ordinary Shares S - Sale D 33.0900 -3,121 -103 0
2021-07-14 2021-07-13 4 Crockett Nigel BCYC Ordinary Shares S - Sale D 32.4100 -69,580 -2,255 3,121
2021-07-14 2021-07-13 4 Crockett Nigel BCYC Ordinary Shares M - Exercise D 15.3600 13,019 200 72,701
2021-07-14 2021-07-13 4 Crockett Nigel BCYC Ordinary Shares M - Exercise D 9.8200 19,256 189 59,682
2021-07-14 2021-07-13 4 Crockett Nigel BCYC Ordinary Shares M - Exercise D 11.6600 40,426 471 40,426
2021-07-14 2021-07-12 4 Crockett Nigel BCYC Employee Stock Option (right to buy) M - Exercise D 15.36 -974 43,783
2021-07-14 2021-07-12 4 Crockett Nigel BCYC Employee Stock Option (right to buy) M - Exercise D 9.82 -1,723 58,006
2021-07-14 2021-07-12 4 Crockett Nigel BCYC Employee Stock Option (right to buy) M - Exercise D 11.66 -4,331 103,086
2021-07-14 2021-07-12 4 Crockett Nigel BCYC Ordinary Shares S - Sale D 32.0300 -7,028 -225 0
2021-07-14 2021-07-12 4 Crockett Nigel BCYC Ordinary Shares M - Exercise D 15.3600 974 15 7,028
2021-07-14 2021-07-12 4 Crockett Nigel BCYC Ordinary Shares M - Exercise D 9.8200 1,723 17 6,054
2021-07-14 2021-07-12 4 Crockett Nigel BCYC Ordinary Shares M - Exercise D 11.6600 4,331 50 4,331
2021-07-08 2021-07-06 4 Crockett Nigel BCYC Employee Stock Option (right to buy) M - Exercise D 9.82 -271 59,729
2021-07-08 2021-07-06 4 Crockett Nigel BCYC Ordinary Shares S - Sale D 32.0000 -271 -9 0
2021-07-08 2021-07-06 4 Crockett Nigel BCYC Ordinary Shares M - Exercise D 9.8200 271 3 271
2021-05-10 2021-05-07 4 Lee Kevin BCYC Stock Option (right to buy) M - Exercise D 14.00 -5,604 414,544
2021-05-10 2021-05-07 4 Lee Kevin BCYC Ordinary Shares S - Sale D 32.2300 -5,604 -181 254,734
2021-05-10 2021-05-07 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 5,604 78 260,338
2021-05-10 2021-05-06 4 Lee Kevin BCYC Stock Option (right to buy) M - Exercise D 14.00 -1,716 420,148
2021-05-10 2021-05-06 4 Lee Kevin BCYC Ordinary Shares S - Sale D 32.1400 -1,716 -55 254,734
2021-05-10 2021-05-06 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 1,716 24 256,450
2021-05-05 2021-05-04 4 Lee Kevin BCYC Stock Option (right to buy) M - Exercise D 14.00 -897 421,864
2021-05-05 2021-05-04 4 Lee Kevin BCYC Ordinary Shares S - Sale D 32.0300 -897 -29 254,734
2021-05-05 2021-05-04 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 897 13 255,631
2021-05-05 2021-05-03 4 Lee Kevin BCYC Stock Option (right to buy) M - Exercise D 14.00 -3,391 422,761
2021-05-05 2021-05-03 4 Lee Kevin BCYC Ordinary Shares S - Sale D 32.1600 -3,391 -109 254,734
2021-05-05 2021-05-03 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 3,391 47 258,125
2021-04-30 2021-04-30 4 Lee Kevin BCYC Stock Option (Right to Buy) M - Exercise D 14.00 -30,406 426,152
2021-04-30 2021-04-30 4 Lee Kevin BCYC Ordinary Shares S - Sale D 30.8800 -26,635 -822 254,734
2021-04-30 2021-04-30 4 Lee Kevin BCYC Ordinary Shares S - Sale D 29.8900 -3,771 -113 281,369
2021-04-30 2021-04-30 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 30,406 426 285,140
2021-04-30 2021-04-29 4 Lee Kevin BCYC Stock Option (Right to Buy) M - Exercise D 14.00 -6,018 456,558
2021-04-30 2021-04-29 4 Lee Kevin BCYC Ordinary Shares S - Sale D 30.9500 -1,609 -50 254,734
2021-04-30 2021-04-29 4 Lee Kevin BCYC Ordinary Shares S - Sale D 30.3500 -4,409 -134 256,343
2021-04-30 2021-04-29 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 6,018 84 260,752
2021-04-30 2021-04-28 4 Lee Kevin BCYC Stock Option (Right to Buy) M - Exercise D 14.00 -22,495 462,576
2021-04-30 2021-04-28 4 Lee Kevin BCYC Ordinary Shares S - Sale D 33.3500 -200 -7 254,734
2021-04-30 2021-04-28 4 Lee Kevin BCYC Ordinary Shares S - Sale D 32.3000 -1,460 -47 254,934
2021-04-30 2021-04-28 4 Lee Kevin BCYC Ordinary Shares S - Sale D 31.2200 -14,348 -448 256,394
2021-04-30 2021-04-28 4 Lee Kevin BCYC Ordinary Shares S - Sale D 30.4300 -6,487 -197 270,742
2021-04-30 2021-04-28 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 22,495 315 277,229
2021-04-28 2021-04-27 4 Lee Kevin BCYC Ordinary Shares S - Sale D 31.4100 -358 -11 254,734
2021-04-28 2021-04-27 4 Lee Kevin BCYC Ordinary Shares S - Sale D 30.6600 -6,278 -192 255,092
2021-04-28 2021-04-27 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 6,636 93 261,370
2021-04-28 2021-04-26 4 Lee Kevin BCYC Stock Option (Right to Buy) M - Exercise D 14.00 -6,636 485,071
2021-04-28 2021-04-26 4 Lee Kevin BCYC Stock Option (Right to Buy) M - Exercise D 14.00 -14,545 491,707
2021-04-28 2021-04-26 4 Lee Kevin BCYC Ordinary Shares S - Sale D 31.5000 -13,896 -438 254,734
2021-04-28 2021-04-26 4 Lee Kevin BCYC Ordinary Shares S - Sale D 30.6300 -4,715 -144 268,630
2021-04-28 2021-04-26 4 Lee Kevin BCYC Ordinary Shares M - Exercise D 14.0000 14,545 204 273,345
2021-04-09 2021-04-08 4 Legault Pierre BCYC Stock Option (Right to Buy) M - Exercise D 8.74 -24,838 173,312
2021-04-09 2021-04-08 4 Legault Pierre BCYC Ordinary Shares S - Sale D 32.1300 -239 -8 0
2021-04-09 2021-04-08 4 Legault Pierre BCYC Ordinary Shares S - Sale D 31.4000 -12,099 -380 239
2021-04-09 2021-04-08 4 Legault Pierre BCYC Ordinary Shares S - Sale D 32.0000 -12,500 -400 12,338
2021-04-09 2021-04-08 4 Legault Pierre BCYC Ordinary Shares M - Exercise D 8.7400 24,838 217 24,838
2021-04-07 2021-04-05 4 Legault Pierre BCYC Stock Option (Right to Buy) M - Exercise D 8.83 -162 198,150
2021-04-07 2021-04-05 4 Legault Pierre BCYC Ordinary Shares S - Sale D 31.0700 -162 -5 0
2021-04-07 2021-04-05 4 Legault Pierre BCYC Ordinary Shares M - Exercise D 8.8300 162 1 162
2021-04-02 2021-03-31 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 30.0000 -10,000 -300 28,321
2021-04-02 2021-03-31 4 Legault Pierre BCYC Stock Option (Right to Buy) M - Exercise D 8.78 -10,000 198,312
2021-04-02 2021-03-31 4 Legault Pierre BCYC Ordinary Shares S - Sale D 30.0000 -10,000 -300 0
2021-04-02 2021-03-31 4 Legault Pierre BCYC Ordinary Shares M - Exercise D 8.7800 10,000 88 10,000
2021-03-19 2021-03-17 4 Gutierrez-Ramos Jose-Carlos BCYC Stock Option (right to buy) A - Award D 27.90 32,000 32,000
2021-03-19 2021-03-17 4 Legault Pierre BCYC Stock Option (Right to Buy) M - Exercise D 8.85 -7,784 208,312
2021-03-19 2021-03-17 4 Legault Pierre BCYC Ordinary Shares S - Sale D 29.0000 -7,784 -226 0
2021-03-19 2021-03-17 4 Legault Pierre BCYC Ordinary Shares M - Exercise D 8.8500 7,784 69 7,784
2021-03-16 2021-03-12 4 Legault Pierre BCYC Stock Option (Right to Buy) M - Exercise D 8.86 -2,216 216,096
2021-03-16 2021-03-12 4 Legault Pierre BCYC Ordinary Shares S - Sale D 29.0000 -2,216 -64 0
2021-03-16 2021-03-12 4 Legault Pierre BCYC Ordinary Shares M - Exercise D 8.8600 2,216 20 2,216
2021-03-16 2021-03-15 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 28.0000 -217 -6 38,321
2021-03-16 2021-03-12 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 29.0000 -283 -8 38,538
2021-03-16 2021-03-12 4 Keen Nicholas BCYC Ordinary Shares S - Sale D 28.4800 -9,500 -271 38,821
2021-02-09 2021-02-05 4 Lee Kevin BCYC Ordinary Shares S - Sale D 31.0000 -100 -3 258,800
2021-01-21 2021-01-20 4 Lee Kevin BCYC Ordinary Shares S - Sale D 33.0000 -351 -12 258,900
2021-01-21 2021-01-20 4 Lee Kevin BCYC Ordinary Shares S - Sale D 32.0200 -100 -3 259,251
2021-01-21 2021-01-20 4 Lee Kevin BCYC Ordinary Shares S - Sale D 31.3272 -734 -23 259,351
2021-01-21 2021-01-19 4 Lee Kevin BCYC Ordinary Shares S - Sale D 31.0900 -100 -3 260,085
2021-01-21 2021-01-19 4 Lee Kevin BCYC Ordinary Shares S - Sale D 30.2193 -371 -11 260,185
2021-01-21 2021-01-19 4 Lee Kevin BCYC Ordinary Shares S - Sale D 29.1389 -4,529 -132 260,556
2021-01-21 2021-01-19 4 Kalowski Lee BCYC Stock Option (Right to Buy) M - Exercise D 1.59 -15,000 79,774
2021-01-21 2021-01-19 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 30.0000 -15,000 -450 0
2021-01-21 2021-01-19 4 Kalowski Lee BCYC Ordinary Shares M - Exercise D 1.5900 15,000 24 15,000
2021-01-15 2021-01-14 4 Kalowski Lee BCYC Stock Option (Right to Buy) M - Exercise D 1.60 -10,000 94,774
2021-01-15 2021-01-14 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 25.0000 -10,000 -250 0
2021-01-15 2021-01-14 4 Kalowski Lee BCYC Ordinary Shares M - Exercise D 1.6000 10,000 16 10,000
2021-01-15 2021-01-15 4 Lee Kevin BCYC Ordinary Shares S - Sale D 27.0100 -5,000 -135 265,085
2021-01-15 2021-01-14 4 Lee Kevin BCYC Ordinary Shares S - Sale D 25.0000 -5,000 -125 270,085
2021-01-05 2021-01-04 4 Winter Gregory Paul BCYC Stock Option (right to buy) A - Award D 17.95 19,000 19,000
2021-01-05 2021-01-04 4 Smethurst Dominic BCYC Employee Stock Option (right to buy) A - Award D 17.95 27,621 27,621
2021-01-05 2021-01-04 4 Skynner Michael BCYC Employee Stock Option (right to buy) A - Award D 17.95 70,500 70,500
2021-01-05 2021-01-04 4 Legault Pierre BCYC Stock Option (right to buy) A - Award D 17.95 38,000 38,000
2021-01-05 2021-01-04 4 Lee Kevin BCYC Employee Stock Option (right to buy) A - Award D 17.95 250,000 250,000
2021-01-05 2021-01-04 4 Kender Richard N BCYC Stock Option (right to buy) A - Award D 17.95 19,000 19,000
2021-01-05 2021-01-04 4 Keen Nicholas BCYC Employee Stock Option (right to buy) A - Award D 17.95 70,500 70,500
2021-01-05 2021-01-04 4 Kalowski Lee BCYC Employee Stock Option (right to buy) A - Award D 17.95 70,500 70,500
2021-01-05 2021-01-04 4 Jordan Veronica GH BCYC Stock Option (right to buy) A - Award D 17.95 19,000 19,000
2021-01-05 2021-01-04 4 Crockett Nigel BCYC Employee Stock Option (right to buy) A - Award D 17.95 70,500 70,500
2021-01-05 2021-01-04 4 Bourque Janice BCYC Stock Option (right to buy) A - Award D 17.95 19,000 19,000
2021-01-05 2021-01-04 4 BINGHAM KATE BCYC Stock Option (right to buy) A - Award D 17.95 19,000 19,000
2020-12-03 2020-12-01 4 Kalowski Lee BCYC Stock Option (Right to Buy) M - Exercise D 1.56 -7,500 104,774
2020-12-03 2020-12-01 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 22.5000 -7,500 -169 0
2020-12-03 2020-12-01 4 Kalowski Lee BCYC Ordinary Shares M - Exercise D 1.5600 7,500 12 7,500
2020-11-30 2020-11-27 4 Kalowski Lee BCYC Stock Option (Right to Buy) M - Exercise D 1.56 -530 112,274
2020-11-30 2020-11-27 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 20.0000 -530 -11 0
2020-11-30 2020-11-27 4 Kalowski Lee BCYC Ordinary Shares M - Exercise D 1.5600 530 1 530
2020-11-25 2020-11-25 4 Kalowski Lee BCYC Stock Option (Right to Buy) M - Exercise D 1.56 -9,781 112,804
2020-11-25 2020-11-25 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 20.0700 -9,781 -196 0
2020-11-25 2020-11-25 4 Kalowski Lee BCYC Ordinary Shares M - Exercise D 1.5600 9,781 15 9,781
2020-11-25 2020-11-23 4 Kalowski Lee BCYC Stock Option (Right to Buy) M - Exercise D 1.56 -17,189 122,585
2020-11-25 2020-11-23 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 20.3800 -213 -4 0
2020-11-25 2020-11-23 4 Kalowski Lee BCYC Ordinary Shares S - Sale D 19.8200 -16,976 -336 213
2020-11-25 2020-11-23 4 Kalowski Lee BCYC Ordinary Shares M - Exercise D 1.5600 17,189 27 17,189
2020-09-18 2020-07-15 4 GLAXOSMITHKLINE PLC BCYC Common Stock S - Sale I 19.2500 -78 -2 1,910,531
2020-09-18 2020-07-15 4 GLAXOSMITHKLINE PLC BCYC Common Stock S - Sale I 19.4016 -3,069 -60 1,910,609
2020-09-18 2020-07-14 4 GLAXOSMITHKLINE PLC BCYC Common Stock S - Sale I 19.2740 -1,597 -31 1,913,678
2020-08-25 2020-08-21 4 Smethurst Dominic BCYC Employee Stock Option (right to buy) A - Award D 18.55 120,000 120,000
2020-04-27 2019-06-28 4/A Keen Nicholas BCYC Stock Option (Right to Buy) A - Award D 14.00 177,404 177,404
2020-04-27 2019-06-28 4/A Kalowski Lee BCYC Stock Option (Right to Buy) A - Award D 14.00 283,414 283,414
2020-04-27 2019-06-28 4/A Skynner Michael BCYC Stock Option (Right to Buy) A - Award D 14.00 183,895 183,895
2020-04-27 2019-06-28 4/A Lee Kevin BCYC Stock Option (Right to Buy) A - Award D 14.00 506,252 506,252
2020-04-27 2019-06-28 4/A Legault Pierre BCYC Stock Option (Right to Buy) A - Award D 14.00 116,827 116,827
2020-04-16 2020-04-14 4 Winter Gregory Paul BCYC Series A Preferred Shares Warrant M - Exercise D -71,450 71,450
2020-04-16 2020-04-14 4 Winter Gregory Paul BCYC Ordinary Shares M - Exercise D 71,450 163,927
2020-02-25 2020-02-21 4 Crockett Nigel BCYC Employee Stock Option (right to buy) A - Award D 15.36 44,757 44,757
2020-01-06 2019-09-26 4/A Crockett Nigel BCYC Employee Stock Option (Right to Buy) A - Award D 11.66 107,417 107,417
2020-01-06 2020-01-02 4 Kender Richard N BCYC Stock Option (right to buy) A - Award D 9.82 8,202 8,202
2020-01-06 2020-01-02 4 Kender Richard N BCYC Stock Option (right to buy) A - Award D 9.82 16,000 16,000
2020-01-06 2020-01-02 4 Legault Pierre BCYC Stock Option (right to buy) A - Award D 9.82 32,000 32,000
2020-01-06 2020-01-02 4 Bourque Janice BCYC Stock Option (right to buy) A - Award D 9.82 8,202 8,202
2020-01-06 2020-01-02 4 Bourque Janice BCYC Stock Option (right to buy) A - Award D 9.82 16,000 16,000
2020-01-06 2020-01-02 4 Crockett Nigel BCYC Employee Stock Option (right to buy) A - Award D 9.82 60,000 60,000
2020-01-06 2020-01-02 4 Jordan Veronica GH BCYC Stock Option (right to buy) A - Award D 9.82 16,000 16,000
2020-01-06 2020-01-02 4 Keen Nicholas BCYC Employee Stock Option (right to buy) A - Award D 9.82 60,000 60,000
2020-01-06 2020-01-02 4 Kalowski Lee BCYC Employee Stock Option (right to buy) A - Award D 9.82 60,000 60,000
2020-01-06 2020-01-02 4 Skynner Michael BCYC Employee Stock Option (right to buy) A - Award D 9.82 60,000 60,000
2020-01-06 2020-01-02 4 Lee Kevin BCYC Employee Stock Option (right to buy) A - Award D 9.82 210,000 210,000
2020-01-06 2020-01-02 4 Winter Gregory Paul BCYC Stock Option (right to buy) A - Award D 9.82 16,000 16,000
2020-01-06 2020-01-02 4 BINGHAM KATE BCYC Stock Option (right to buy) A - Award D 9.82 16,000 16,000
2019-12-19 2019-12-17 4 Jordan Veronica GH BCYC Stock Option (right to buy) A - Award D 8.30 32,000 32,000
2019-09-30 2019-09-26 4 Bourque Janice BCYC Stock Option (Right to Buy) A - Award D 11.66 23,798 23,798
2019-09-30 2019-09-26 4 Crockett Nigel BCYC Employee Stock Option (Right to Buy) A - Award D 11.66 152,174 152,174
2019-09-30 2019-09-26 4 Kender Richard N BCYC Stock Option (Right to Buy) A - Award D 11.66 23,798 23,798
2019-06-03 2019-05-28 4 TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes BCYC Series B2 Preferred Shares Warrants X - Other I -139,264 0
2019-06-03 2019-05-28 4 TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes BCYC Ordinary Shares P - Purchase I 14.0000 364,286 5,100 1,957,961
2019-06-03 2019-05-28 4 TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes BCYC Ordinary Shares X - Other I 139,264 1,593,675
2019-06-03 2019-05-28 4 TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes BCYC Ordinary Shares C - Conversion I 1,454,411 1,454,411
2019-06-03 2019-05-24 4 TYBOURNE CAPITAL MANAGEMENT HK LTD See Footnotes BCYC Series B2 Preferred Shares C - Conversion I -1,454,411 0
2019-05-31 2019-05-28 4/A NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD BCYC Series B2 Preferred Shares C - Conversion I -206,767 0
2019-05-31 2019-05-28 4/A NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD BCYC Series B1 Preferred Shares Warrants X - Other I -141,668 0
2019-05-31 2019-05-28 4/A NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD BCYC Series B1 Preferred Shares C - Conversion I -1,272,733 0
2019-05-31 2019-05-28 4/A NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD BCYC Ordinary Shares C - Conversion I 206,767 1,427,151
2019-05-31 2019-05-28 4/A NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD BCYC Ordinary Shares X - Other I 141,668 1,207,410
2019-05-31 2019-05-28 4/A NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD BCYC Ordinary Shares C - Conversion I 1,272,733 1,081,823
2019-05-31 2019-05-29 4 Cambridge Innovation Capital (Jersey) Ltd BCYC Ordinary Shares P - Purchase D 14.0000 314,286 4,400 1,751,437
2019-05-31 2019-05-28 4 Cambridge Innovation Capital (Jersey) Ltd BCYC Series B2 Preferred Shares C - Conversion D -229,741 0
2019-05-31 2019-05-28 4 Cambridge Innovation Capital (Jersey) Ltd BCYC Series B1 Preferred Shares Warrants X - Other D -125,587 0
2019-05-31 2019-05-28 4 Cambridge Innovation Capital (Jersey) Ltd BCYC Series B1 Preferred Shares C - Conversion D -1,081,823 0
2019-05-31 2019-05-28 4 Cambridge Innovation Capital (Jersey) Ltd BCYC Ordinary Shares C - Conversion D 229,741 1,437,151
2019-05-31 2019-05-28 4 Cambridge Innovation Capital (Jersey) Ltd BCYC Ordinary Shares X - Other D 125,587 1,207,410
2019-05-31 2019-05-28 4 Cambridge Innovation Capital (Jersey) Ltd BCYC Ordinary Shares C - Conversion D 1,081,823 1,081,823
2019-05-30 2019-05-28 4 Vertex Global Healthcare Fund I Pte Ltd. BCYC Series B2 Preferred Shares C - Conversion D -206,767 0
2019-05-30 2019-05-28 4 Vertex Global Healthcare Fund I Pte Ltd. BCYC Series B1 Preferred Shares Warrants X - Other D -141,668 0
2019-05-30 2019-05-28 4 Vertex Global Healthcare Fund I Pte Ltd. BCYC Series B1 Preferred Shares C - Conversion D -1,272,733 0
2019-05-30 2019-05-28 4 Vertex Global Healthcare Fund I Pte Ltd. BCYC Ordinary Shares C - Conversion D 206,767 1,621,168
2019-05-30 2019-05-28 4 Vertex Global Healthcare Fund I Pte Ltd. BCYC Ordinary Shares X - Other D 141,668 1,414,401
2019-05-30 2019-05-28 4 Vertex Global Healthcare Fund I Pte Ltd. BCYC Ordinary Shares C - Conversion D 1,272,733 1,272,733
2019-05-30 2019-05-28 4 Keen Nicholas BCYC Stock Option (Right to Buy) A - Award D 14.00 177,404 177,404
2019-05-30 2019-05-28 4 Skynner Michael BCYC Stock Option (Right to Buy) A - Award D 14.00 183,895 183,895
2019-05-30 2019-05-28 4 Kalowski Lee BCYC Stock Option (Right to Buy) A - Award D 14.00 283,414 283,414
2019-05-30 2019-05-28 4 Leone Peter Brian BCYC Stock Option (Right to Buy) A - Award D 14.00 43,269 43,269
2019-05-30 2019-05-28 4 Lee Kevin BCYC Stock Option (Right to Buy) A - Award D 14.00 506,252 506,252
2019-05-30 2019-05-28 4 Legault Pierre BCYC Stock Option (Right to Buy) A - Award D 14.00 116,827 116,827
2019-05-30 2019-05-28 4 HARLAND DEBORAH BCYC Series B1 Preferred Shares C - Conversion I -636,366 0
2019-05-30 2019-05-28 4 HARLAND DEBORAH BCYC Series A Preferred Shares C - Conversion I -893,195 0
2019-05-30 2019-05-28 4 HARLAND DEBORAH BCYC Ordinary Shares P - Purchase I 14.0000 385,714 5,400 1,915,275
2019-05-30 2019-05-28 4 HARLAND DEBORAH BCYC Ordinary Shares C - Conversion I 636,366 1,529,561
2019-05-30 2019-05-28 4 HARLAND DEBORAH BCYC Ordinary Shares C - Conversion I 893,195 893,195
2019-05-30 2019-05-28 4 BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. BCYC Series B1 Preferred Shares C - Conversion I -13,169 0
2019-05-30 2019-05-28 4 BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. BCYC Series A Preferred Shares C - Conversion I -18,485 0
2019-05-30 2019-05-28 4 BINGHAM KATE By SV Life Sciences Fund V, L.P. BCYC Series B1 Preferred Shares C - Conversion I -623,196 0
2019-05-30 2019-05-28 4 BINGHAM KATE By SV Life Sciences Fund V, L.P. BCYC Series A Preferred Shares C - Conversion I -874,709 0
2019-05-30 2019-05-28 4 BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. BCYC Ordinary Shares P - Purchase I 14.0000 7,983 112 39,637
2019-05-30 2019-05-28 4 BINGHAM KATE By SV Life Sciences Fund V, L.P. BCYC Ordinary Shares P - Purchase I 14.0000 377,732 5,288 1,875,637
2019-05-30 2019-05-28 4 BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. BCYC Ordinary Shares C - Conversion I 13,169 31,654
2019-05-30 2019-05-28 4 BINGHAM KATE By SV Life Sciences Fund V Strategic Partners. L.P. BCYC Ordinary Shares C - Conversion I 18,485 18,485
2019-05-30 2019-05-28 4 BINGHAM KATE By SV Life Sciences Fund V, L.P. BCYC Ordinary Shares C - Conversion I 623,196 1,497,905
2019-05-30 2019-05-28 4 BINGHAM KATE By SV Life Sciences Fund V, L.P. BCYC Ordinary Shares C - Conversion I 874,709 874,709
2019-05-30 2019-05-28 4 Anstey Michael By Cambridge Innovation Capital (Jersey) Limited BCYC Series B2 Preferred Shares C - Conversion I 229,741 0
2019-05-30 2019-05-28 4 Anstey Michael By Cambridge Innovation Capital (Jersey) Limited BCYC Series B1 Preferred Shares Warrants X - Other I 125,587 0
2019-05-30 2019-05-28 4 Anstey Michael By Cambridge Innovation Capital (Jersey) Limited BCYC Series B1 Preferred Shares C - Conversion I 1,081,823 0
2019-05-30 2019-05-28 4 Anstey Michael By Cambridge Innovation Capital (Jersey) Limited BCYC Ordinary Shares P - Purchase I 14.0000 314,286 4,400 1,751,437
2019-05-30 2019-05-28 4 Anstey Michael By Cambridge Innovation Capital (Jersey) Limited BCYC Ordinary Shares C - Conversion I 229,741 1,437,151
2019-05-30 2019-05-28 4 Anstey Michael By Cambridge Innovation Capital (Jersey) Limited BCYC Ordinary Shares X - Other I 125,587 1,207,410
2019-05-30 2019-05-28 4 Anstey Michael By Cambridge Innovation Capital (Jersey) Limited BCYC Ordinary Shares C - Conversion I 1,081,823 1,081,823
2019-05-30 2019-05-28 4 SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. BCYC Series B1 Preferred Shares C - Conversion I -13,169 0
2019-05-30 2019-05-28 4 SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. BCYC Series A Preferred Shares C - Conversion I -18,485 0
2019-05-30 2019-05-28 4 SVLSF V, LLC By SV Life Sciences Fund V, L.P. BCYC Series B1 Preferred Shares C - Conversion I -623,196 0
2019-05-30 2019-05-28 4 SVLSF V, LLC By SV Life Sciences Fund V, L.P. BCYC Series A Preferred Shares C - Conversion I -874,709 0
2019-05-30 2019-05-28 4 SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. BCYC Ordinary Shares P - Purchase I 14.0000 7,983 112 39,637
2019-05-30 2019-05-28 4 SVLSF V, LLC By SV Life Sciences Fund V, L.P. BCYC Ordinary Shares P - Purchase I 14.0000 377,732 5,288 1,875,637
2019-05-30 2019-05-28 4 SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. BCYC Ordinary Shares C - Conversion I 13,169 31,654
2019-05-30 2019-05-28 4 SVLSF V, LLC By SV Life Sciences Fund V Strategic Partners. L.P. BCYC Ordinary Shares C - Conversion I 18,485 18,485
2019-05-30 2019-05-28 4 SVLSF V, LLC By SV Life Sciences Fund V, L.P. BCYC Ordinary Shares C - Conversion I 623,196 1,497,905
2019-05-30 2019-05-28 4 SVLSF V, LLC By SV Life Sciences Fund V, L.P. BCYC Ordinary Shares C - Conversion I 874,709 874,709
2019-05-30 2019-05-28 4 NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD BCYC Series B2 Preferred Shares C - Conversion I -206,767 0
2019-05-30 2019-05-28 4 NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD BCYC Series B1 Preferred Shares Warrants X - Other I -141,668 0
2019-05-30 2019-05-28 4 NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD BCYC Series B1 Preferred Shares C - Conversion I -1,272,733 0
2019-05-30 2019-05-28 4 NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD BCYC Ordinary Shares C - Conversion I 206,767 1,621,168
2019-05-30 2019-05-28 4 NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD BCYC Ordinary Shares X - Other I 141,668 1,414,401
2019-05-30 2019-05-28 4 NG CAROLYN By Vertex Global Healthcare Fund I PTE. LTD BCYC Ordinary Shares C - Conversion I 1,272,733 1,272,733
2019-05-30 2019-05-27 4 NG CAROLYN By Vertex Venture Management PTE LTD. BCYC Ordinary Shares P - Purchase I 14.0000 571,429 8,000 571,429
2019-05-30 2019-05-28 4 Winter Gregory Paul BCYC Series A Preferred Shares C - Conversion D -42,870 0
2019-05-30 2019-05-28 4 Winter Gregory Paul BCYC Ordinary Shares C - Conversion D 42,870 92,477
2019-05-30 2019-05-28 4 Novartis Bioventures Ltd BCYC Series B1 Preferred Shares C - Conversion D -636,366 0
2019-05-30 2019-05-28 4 Novartis Bioventures Ltd BCYC Series A Preferred Shares Warrants X - Other D -71,450 0
2019-05-30 2019-05-28 4 Novartis Bioventures Ltd BCYC Series A Preferred Shares C - Conversion D -893,195 0
2019-05-30 2019-05-28 4 Novartis Bioventures Ltd BCYC Ordinary Shares P - Purchase D 14.0000 168,630 2,361 1,769,641
2019-05-30 2019-05-28 4 Novartis Bioventures Ltd BCYC Ordinary Shares C - Conversion D 636,366 1,601,011
2019-05-30 2019-05-28 4 Novartis Bioventures Ltd BCYC Ordinary Shares X - Other D 71,450 964,645
2019-05-30 2019-05-28 4 Novartis Bioventures Ltd BCYC Ordinary Shares C - Conversion D 893,195 893,195
2019-05-30 2019-05-28 4 GLAXOSMITHKLINE PLC BCYC Series B1 Preferred Shares C - Conversion I -445,323 0
2019-05-30 2019-05-28 4 GLAXOSMITHKLINE PLC BCYC Series A Preferred Shares C - Conversion I -625,049 0
2019-05-30 2019-05-28 4 GLAXOSMITHKLINE PLC BCYC Ordinary Shares P - Purchase I 14.0000 385,714 5,400 1,915,275
2019-05-30 2019-05-28 4 GLAXOSMITHKLINE PLC BCYC Ordinary Shares C - Conversion I 636,366 1,529,561
2019-05-30 2019-05-28 4 GLAXOSMITHKLINE PLC BCYC Ordinary Shares C - Conversion I 893,195 893,195
2019-05-22 3 Skynner Michael BCYC Ordinary Shares D 82,246
2019-05-22 3 Skynner Michael BCYC Ordinary Shares D 82,246
2019-05-22 3 Skynner Michael BCYC Ordinary Shares D 82,246
2019-05-22 3 Lee Kevin BCYC Ordinary Shares D 550,170
2019-05-22 3 Lee Kevin BCYC Ordinary Shares D 550,170
2019-05-22 3 Lee Kevin BCYC Ordinary Shares D 550,170
2019-05-22 3 Keen Nicholas BCYC Ordinary Shares D 96,642
2019-05-22 3 Keen Nicholas BCYC Ordinary Shares D 96,642
2019-05-22 3 Keen Nicholas BCYC Ordinary Shares D 96,642
2019-05-22 3 Winter Gregory Paul BCYC Ordinary Shares D 99,214
2019-05-22 3 Winter Gregory Paul BCYC Ordinary Shares D 99,214
2019-05-22 3 Winter Gregory Paul BCYC Ordinary Shares D 99,214
P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award, or other acquisition of securities from the company (such as an option)
C
Conversion of derivative
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
G
Gift of securities by or to the insider
K
Equity swaps and similar hedging transactions
M
Exercise or conversion of derivative security received from the company (such as an option)
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)
Other Listings
DE:50BA €5.95
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista